← FDA Drug Approvals (Drugs@FDA)
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2022-02-23
Drug application
- FDA Application #
ANDA216211- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Generic name
- TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- Active ingredients
- HYDROCHLOROTHIAZIDE; TRIAMTERENE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2022-02-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown